Rethinking credible evidence synthesis
- 17 January 2012
- Vol. 344 (jan17 2) , d7898
- https://doi.org/10.1136/bmj.d7898
Abstract
After publication of a Cochrane review into the effectiveness of oseltamivir in 2009, the reviewers got access to thousands of pages of previously unavailable data. Peter Doshi and colleagues describe how it shook their faith in published reports and changed their approach to systematic reviewsKeywords
This publication has 12 references indexed in Scilit:
- Does Oseltamivir Really Reduce Complications of Influenza?Clinical Infectious Diseases, 2011
- Unseen World of Clinical Trials Emerges From U.S. DatabaseScience, 2011
- EMA's response to articlesBMJ, 2011
- Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical TrialsClinical Infectious Diseases, 2011
- Opening up data at the European Medicines AgencyBMJ, 2011
- Ensuring safe and effective drugs: who can do what it takes?BMJ, 2011
- Safety and pharmacokinetics of oseltamivir at standard and high dosagesInternational Journal of Antimicrobial Agents, 2010
- Point-by-point response from Roche to BMJ questionsBMJ, 2009
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of internal medicine (1960), 2003